Myriad Genetics, Inc. · NASDAQ:MYGN
Fox Jennifer Lynne received 39,370 Myriad Genetics, Inc. shares as an award (Form 4)
Traded Nov 1, 2026 · Filed Nov 2, 2026
On Nov 1, 2026, Fox Jennifer Lynne (Chief Legal & Corp Strategy) received 39,370 Myriad Genetics, Inc. shares as an award, leaving 345,334 shares. Filed Nov 2, 2026 (Form 4).
- Awarded
- 39,370 shares
- Holding after
- 345,334 shares
- Trading plan
- No
- Role
- Chief Legal & Corp Strategy
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 1, 2026 | Common Stock | Award | 39,370 | 345,334 | Direct |
Source
Download original · View original at SEC
Related
- Myriad Genetics, Inc.
- Fox Jennifer Lynne
- Myriad Genetics, Inc. shareholders
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Form 4 · Davis Mark Steven · Nov 19, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Nov 16, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Oct 27, 2026
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026